How does UCP1 work?
UCP1 is the inner-mitochondrial-membrane protein that lets brown and beige adipocytes dissipate the proton gradient as heat. This page covers its identity, its pathway context, and what the research literature reports on
Uncoupling protein 1 (UCP1), also called thermogenin, is a member of the mitochondrial anion carrier protein family and the defining molecular marker of brown adipocytes. It is an inner mitochondrial membrane protein whose canonical activity is to conduct protons across that membrane independently of ATP synthase, short-circuiting the proton-motive force that oxidative phosphorylation normally uses to drive ATP synthesis and releasing the stored energy as heat. The evidence block supplied for this page does not give a sequence, formula or molecular weight for UCP1, so none is stated here.
The work described below centres on the TGF-β superfamily and its downstream SMAD signalling, together with adrenergic receptor signalling, as the pathways through which adipose thermogenic programmes are studied.
Research Studies
Follistatin and adipose browning in atherosclerosis models
Follistatin (FST) binds and neutralises members of the TGF-β superfamily, and is reported to regulate skeletal muscle, adipose and bone homeostasis. In mice, FST promotes adipose browning and enhances energy metabolism, with improved plasma lipid profiles and metabolic health. Because brown adipose tissue (BAT) activation has been associated with reduced atherosclerosis, one group used transcriptomic and metabolomic analysis of the Hybrid Mouse Diversity Panel (HMDP) and found that Fst expression was negatively correlated with aortic lesion area [1].
GDF-11 and cold-induced browning of white adipose tissue
Growth differentiation factor 11 (GDF-11) is a circulating TGF-β superfamily member. In a study of mice exposed to cold to induce browning, GDF-11 expression and SMAD2/3 activation were assessed in BAT, visceral and subcutaneous white adipose tissue (WAT), and skeletal muscle, with in vivo results combined with in vitro approaches including 3T3- cells [2]. The work examined whether GDF-11 regulates WAT browning and the mechanisms underlying it.
Finerenone and epicardial adipose tissue in a cardiac trial
Finerenone is a nonsteroidal mineralocorticoid receptor antagonist with anti-inflammatory, antifibrotic and metabolic effects. It was associated with a lower incidence of atrial fibrillation in prior large trials, and preclinical studies suggest it promotes browning of adipose tissue and improves epicardial adipose tissue (EAT) characteristics. A single-centre, randomised, investigator-blinded pilot trial is enrolling 40 patients to test finerenone after catheter ablation with pulmonary vein isolation, a setting in which 20–30% of patients experience atrial fibrillation recurrence within one year [3].
Exercise and Mediterranean diet in metabolic syndrome
Dietary caloric restriction and physical exercise are both reported to retard or prevent age-related disease and prolong lifespan. A study in middle-aged volunteers with metabolic syndrome is designed to test whether physical exercise and/or a Mediterranean diet preserve adipose tissue functionality and retard skeletal muscle ageing, assessed by mitochondrial biogenesis and accumulation of reactive oxygen species, through pathways homologous to caloric restriction [4].
Syringaresinol and the skeletal muscle SIRT1–FNDC5/irisin axis
Syringaresinol (SYR) is a plant-derived lignan. One study examined whether SYR modulates skeletal muscle SIRT1-related FNDC5/irisin signalling and high-fat-diet-associated metabolic outcomes, using differentiated C2C12 myotubes treated with SYR alongside the SIRT1 activator SRT1720 and the SIRT1 inhibitor EX-527 to assess irisin-related readouts [5].
Time-restricted feeding and HIIT in diabetic rats
A study evaluated the independent and combined effects of time-restricted feeding (TRF) and high-intensity interval training (HIIT) on thermogenesis-related protein abundance in white adipose tissue of diabetic rats. Forty male Wistar rats were divided into normal and diabetic groups [6].
β2-adrenergic receptor stimulation in human adipose-derived stem cells
β-adrenergic receptors drive induction of beige adipocytes in rodents and humans, though whether β2-AR or β3-AR is the dominant human subtype remains debated. One study set out to confirm whether human adipose-derived mesenchymal stem cell (hADSC)-derived adipocytes can serve as a beiging-competent model under human-relevant conditions [7].
Bombesin receptor-activated protein homolog deficiency in high-fat-diet mice
Bombesin receptor-activated protein (BRAP) and its mouse homolog BC004004 are expressed in the central nervous system, though their functions were previously unclear. In feeding experiments, BRAP homolog knockout mice (BC004004-/-) showed reduced preference for a high-fat diet and alleviated metabolic dysfunction under high-fat-diet treatment [8].
Comparison of model systems used across the evidence
| Model | Species / system | Thermogenic or metabolic readout reported |
|---|---|---|
| HMDP transcriptomics and metabolomics | Mouse panel | Fst expression negatively correlated with aortic lesion area [1] |
| Cold exposure | Mouse, plus 3T3- in vitro | GDF-11 expression and SMAD2/3 activation in BAT, WAT and skeletal muscle [2] |
| Catheter ablation pilot trial | Human, 40 patients | Atrial fibrillation recurrence; EAT characteristics [3] |
| Exercise and Mediterranean diet | Human, middle-aged volunteers with metabolic syndrome | Adipose functionality; mitochondrial biogenesis; ROS accumulation [4] |
| C2C12 myotubes | In vitro | SIRT1-related FNDC5/irisin signalling [5] |
| TRF and HIIT | Diabetic rats, 40 male Wistar | Thermogenesis-related protein abundance in WAT [6] |
| hADSC-derived adipocytes | Human, in vitro | Beige adipocyte differentiation under β2-AR stimulation [7] |
| BC004004-/- knockout | Mouse | Food intake and metabolic dysfunction on high-fat diet [8] |
If you are reading this for personal health reasons
The materials described on this page are supplied for laboratory research use only. We do not provide dosing information, medical guidance or recommendations for personal use of any compound. Anyone considering a compound for themselves should speak to a licensed clinician.
Sources
- [1] Follistatin Mitigates Atherosclerosis Through Activation of Arginine Metabolism and Adipose Browning — https://pubmed.ncbi.nlm.nih.gov/42439678/
- [2] GDF-11 triggers cold-induced browning and metabolic activation of adipose tissue — https://pubmed.ncbi.nlm.nih.gov/42296290/
- [3] Finerenone After Catheter Ablation to Reduce Atrial Fibrillation Recurrence — https://clinicaltrials.gov/study/NCT07799519
- [4] Beneficial Effects of Exercise and Healthy Diets on Muscle and Adipose Tissue — https://clinicaltrials.gov/study/NCT01793896
- [5] Syringaresinol activates the skeletal muscle SIRT1-FNDC5/irisin axis to enhance weight management — https://pubmed.ncbi.nlm.nih.gov/42733416/
- [6] Effects of time-restricted feeding and high-intensity interval training on thermogenesis-related protein abundance in white adipose tissue of diabetic rats — https://pubmed.ncbi.nlm.nih.gov/42572539/
- [7] β2-adrenergic receptor stimulation drives differentiation of human adipose-derived mesenchymal stem cells into beige adipocytes — https://europepmc.org/article/PMC/PMC13336291
- [8] Bombesin receptor-activated protein homolog deficiency reduces food intake and alleviates metabolic dysfunction in high-fat diet treated mice — https://pubmed.ncbi.nlm.nih.gov/41932562/